Clinical Trial Update: Clinical Trial of Ultra-high Dose Methylcobalamin for ALS [Phase 3]

View source ↗

Summary

Phase 3 trial of ultra-high dose methylcobalamin for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Ultra-high Dose Methylcobalamin (methylcobalamin)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis | Phase 3 | Status: COMPLETED